Colpocleisis deemed safe for advanced pelvic organ prolapse

Colpocleisis deemed safe for advanced pelvic organ prolapse
Colpocleisis is a safe and effective treatment for advanced pelvic organ prolapse; however, urinary frequency and urgency often persist after the procedure, according to research published in the September issue of Urology.

(HealthDay)—Colpocleisis is a safe and effective treatment for advanced pelvic organ prolapse; however, urinary frequency and urgency often persist after the procedure, according to research published in the September issue of Urology.

Michelle E. Koski, M.D., of the Medical University of South Carolina in Charleston, and colleagues retrospectively characterized outcomes for 53 patients with Pelvic Organ Prolapse Questionnaire stage 3 or greater or Baden Walker grade 3 or greater who had undergone a colpocleisis procedure from 2001 to 2010.

The researchers found that 73.6 percent of the participants underwent total colpocleisis, 26.4 percent had a Le Fort procedure, and 60.4 percent underwent a concomitant sling procedure. After a mean follow-up of 9.3-months, four complications were reported: , pulmonary embolism, clot evacuation, and intraoperative cystotomy repair. None of the patients experienced new urgency, prolapse recurrence, or chronic urinary retention. persisted in four patients and started in one patient of the group who did not undergo a sling procedure. Twenty-two patients completed questionnaires; 90.9 percent reported their condition as much better. However, urinary frequency and urgency were a frequent postoperative complaint (33.3 percent on the Urinary Distress Invetory-6).

"In a selected patient population, colpocleisis is safe and efficacious. Persistent comprise the highest frequency of complaints after colpocleisis, and this must be included in patient counseling," the authors write. "In an aging patient population with expected increase in demand for pelvic floor reconstruction, colpocleisis is a useful approach for the ."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

PISQ-12 validated for patients with pelvic organ prolapse

Mar 03, 2012

(HealthDay) -- The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) has been shown to be a valid measure of sexual function in patients who undergo surgical mesh implantation for treatment ...

Recommended for you

Recorded Ebola deaths top 7,000

16 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

20 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.